Endothelin-1 mediates the alcohol-induced reduction of pancreatic capillary blood flow

J Gastrointest Surg. 1998 Jul-Aug;2(4):379-84. doi: 10.1016/s1091-255x(98)80078-4.

Abstract

Increased plasma endothelin-1 (ET-1) levels in rats after alcohol administration and increased endothelin receptor expression in the pancreas in chronic alcoholic pancreatitis have led to the hypothesis that ET-1 may play a critical role in the pathogenesis of ethanol-induced pancreatic injury through impairment of perfusion. To further test the hypothesis that ET-1 mediates an alcohol-induced reduction of pancreatic perfusion, the present study compares the effect of intravenous alcohol and ET-1 on pancreatic capillary blood flow (PCBF) and investigates whether endothelin receptor blockade prevents the alcohol-induced reduction in PCBF. Anesthetized rats were randomly assigned to receive one of the following: a 1-hour infusion of 2 g/kg alcohol or the volume equivalent of saline solution plus ET-1 (1.25 microgram/kg), a specific endothelin-A receptor antagonist (50 mg/kg), or saline solution (volume equivalent). The pancreas was exposed for intravital microscopy; PCBF was determined at the same location before the test solutions were given, after the infusion, and 1 hour thereafter. Alcohol and ET-1 significantly decreased PCBF from 2.0 nl/min/cap to 1.7 nl/min/cap. The reduction in PCBF was even more pronounced when alcohol and ET-1 were combined (1.5 nl/min/cap), whereas the ET receptor antagonist increased PCBF in saline-treated rats to 2.2 nl/min cap and maintained stable PCBF in alcohol-treated animals. The observation that PCBF is reduced by both alcohol and ET-1 and that the alcohol-induced reduction of PCBF can be aggravated by ET-1 and prevented by a specific endothelin-1 antagonist supports the hypothesis that ET-1 is the mediator of the alcohol-associated reduction of pancreatic perfusion.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Capillaries / drug effects
  • Drug Synergism
  • Endothelin Receptor Antagonists
  • Endothelin-1 / administration & dosage
  • Endothelin-1 / antagonists & inhibitors
  • Endothelin-1 / pharmacology*
  • Ethanol / administration & dosage
  • Ethanol / pharmacology*
  • Female
  • Infusions, Intravenous
  • Microcirculation / drug effects
  • Microscopy
  • Pancreas / blood supply*
  • Pancreas / drug effects
  • Phenylpropionates / pharmacology
  • Placebos
  • Pyrimidines / pharmacology
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Receptors, Endothelin / drug effects
  • Sodium Chloride

Substances

  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Phenylpropionates
  • Placebos
  • Pyrimidines
  • Receptors, Endothelin
  • darusentan
  • Ethanol
  • Sodium Chloride